Answer

Is beta amyloid the cause of Alzheimer's?

Alzheimer's & Amyloid alzheimers amyloid brain-health cognition

By Arun AgrahriLast reviewed 2 timecoded sources

Short answer

Probably not the main cause, but the case is still open. Five credited sources on tape back that, one only in part. One says removing all 4.5 grams of amyloid from a brain would not cure the disease. Precis has read 20 studies only from their abstracts, so none counts yet. Three found that clearing amyloid slowed decline.

Best for:
people following the Alzheimer's research and the new drugs.
Price:
Free to read, with every receipt. Pro is $9 a month or $79 a year and adds AI Ask.
Based on what researchers say in public interviews on YouTube. Educational only, not medical advice. Ask a qualified clinician before changing a supplement, medication, treatment, or testing plan.

What the evidence says

positive partly neutral negative Each researcher and each study counts once per claim, however often they come up.

  1. Leaning for

    Beta amyloid is not the main cause of Alzheimer's disease.

    5 sources: 4 positive, 1 partly.

    Researchers say

    3 positive, 1 partly

    Studies show

    1 positive

    1 cited on tape, not yet checked against the paper

    59 more not counted · see why
    The study is not yet read in full. 20
    We could not confirm who is speaking. 13
    We could not tell what position it takes on this claim. 13
    We could not tell where the evidence comes from. 8
    A host's remark inside an interview. 4
    The study cited could not be identified. 1
    Show the receipts from 5 sources
    1. Louisa Nicola Video · positive · 2 mentions

      on Rangan Chatterjee's channel, at 19:20 · positive · Opinion

      “even if you remove the 4.5 G of amalo from somebody's brain you are still not curing Alzheimer's disease”

      on Rangan Chatterjee's channel, at 04:07 · positive · Opinion

      “we're demonizing amalo and amalo isn't the demon here amalo is actually a great antimicrobial peptide”

    2. Dr. Dale Bredesen Video · positive · 2 mentions

      on FoundMyFitness, at 03:25 · positive · Opinion

      “when you produce it you're at this increased risk for having a degenerative process, but as you indicated, there are many people that produce it”

      on FoundMyFitness, at 56:42 · positive · Opinion

      “it's not the cause of Alzheimer's, it's a mediator”

    3. Francisco Gonzalez-Lima Video · positive · 2 mentions

      on The Drive, at 29:00 · positive · Opinion

      “amyloid-beta hypothesis this is hypothesis completely absolutely false”

      on The Drive, at 1:28:02 · positive · Opinion

      “the amyloid beta is primarily a process that is compensatory when the cells are showing atrophy”

    4. Rudy Tanzi, cited on The Dr. Hyman Show, at 32:28 Study · positive

      “so absent inflammation the amyloid doesn't do anything”

    5. Dr. Peter Attia, on Huberman Lab, at 2:09:00 Video · partly · Opinion

      “it probably set the field on the path towards an overemphasis on amalo beta um and it's not really clear how important amalo is”

Where the sources disagree

Leaning for

Beta amyloid is not the main cause of Alzheimer's disease.

Supports it 4 sources

Researchers

Studies

Partly 1 source

Precis is not affiliated with or endorsed by YouTube or by any researcher, show or publisher we quote. We take no sponsorship, ad or affiliate money, and every verdict is our own review of what was said. How we stay independent

How this moved

5 updates since June 2026. Each one is a dated statement on the record, timecoded to the video.

  1. Latest David Perlmutter, on Mark Hyman's show

    A Cochrane review calls the benefit trivial

    The hardest number in the thread. 17 studies, 20,342 people, about 18 months each. The benefit was described as trivial, while 20 to 25 percent of people on the drugs developed brain bleeding, swelling, or died, against a cost of roughly $40,000 a year.

    on the record @ 18:47
  2. Peter Attia

    Clearing the marker is not treating the disease

    States the lesson the anti-amyloid drugs keep teaching, that removing the marker does not reliably help the patient. It arrives the same week as a claim of reversing p-tau 217, an Alzheimer's blood marker, by treating underlying infection.

    on the record @ 01:23
  3. Gayatri Devi, on Peter Attia's show

    Do not diagnose off a blood amyloid test

    The sharpest turn in the thread. Amyloid shows up in plenty of asymptomatic, functionally healthy older adults, so testing for it that way manufactures patients. The same week, the Nun Study and the reading of amyloid as an immune response both came up again.

    on the record @ 37:41
  4. Mark Hyman

    Reframed as a metabolic and inflammatory disease

    Treats the brain as downstream of metabolism, pointing at vitamin D and homocysteine as markers that both track Alzheimer's risk and move. The Vitacog trial backs the homocysteine result, but only above 11-13 umol/L, and the fix is thinner than the marker.

    on the record @ 09:02
  5. Matthew Walker, on Andrew Huberman's show

    The clearance mechanism, not the cause

    The thread opens on plumbing rather than blame. Deep sleep is when the brain clears beta amyloid and tau, which frames the proteins as waste to be removed rather than as the disease.

    on the record @ 33:01

Nobody has answered

Which marker to act on first. Each replacement for amyloid on the record is a different one, from metabolic markers and homocysteine to p-tau 217, infection and microglial inflammation. No one has put those candidates in rank order, and no one has run a head-to-head.

Detailed Answer

The verdict leans toward amyloid not being the main cause of Alzheimer's. Five credited sources on tape back the claim, one only in part, and none argues against it. Precis has also read 20 studies, only from their abstracts so far, so none counts yet. Three of them point the other way, which keeps the verdict at a lean.

What the counted sources say

Louisa Nicola, a guest on Rangan Chatterjee's show, says removing all 4.5 grams of amyloid from a brain would still not cure Alzheimer's. Dale Bredesen, a guest on Rhonda Patrick's show, calls it a mediator, not the cause. Francisco Gonzalez-Lima, a guest on Peter Attia's show, calls the amyloid hypothesis false.

Attia, a guest on Andrew Huberman's show, backs the claim in part. How much amyloid matters is not clear, he says.

Mark Hyman, on his own show, retells autopsy studies Rudy Tanzi talks about. People who thought normally until they died had brains full of amyloid but no inflammation. As Hyman puts it, "absent inflammation the amyloid doesn't do anything."

What the studies read so far report

Eleven of the 20 studies test drugs that lower amyloid. Five found little or no slowing of decline. Three found the reverse. Lecanemab slowed decline by a moderate amount at 18 months, and donanemab slowed it at 76 weeks. A 2023 pooled analysis tied less plaque to slower decline. The last three were mixed.

The other nine look at people who carry amyloid. Six found that plaque often sits in people who stay free of dementia. One of them estimated that most people with early, silent Alzheimer's changes will never get dementia. Two of the other three found that amyloid still raised the risk of decline.

The drugs that clear amyloid

David Perlmutter, a neurologist and guest on Hyman's show, cites a Cochrane review of 17 trials in 20,342 people. It called the benefit trivial, while 20 to 25 percent of people on the drugs had brain bleeding, swelling or died. His remarks are not counted on this claim.

What no study has tested yet

No study can test "the main cause" head on. Trials test what happens when amyloid is removed. Cohort studies test whether amyloid alone leads to dementia. Precis has not yet searched the genetic evidence, such as inherited mutations that drive amyloid build-up. No one on the record has tested the ideas that would replace amyloid against each other.

What this does not mean

This does not mean amyloid is irrelevant, and no one on the record says so. It is not a reason to stop a prescribed treatment; take that question to your neurologist.

Related Questions

Do the new Alzheimer's drugs work?
They clear plaque, but the benefit is small. In studies Precis has read only from their abstracts, lecanemab and donanemab slowed decline and gantenerumab did not. A 2024 pooled analysis put the benefit far below what patients would notice. Perlmutter, on Hyman's show, cites a Cochrane review of 17 studies in 20,342 people. It called the benefit trivial, while 20 to 25 percent had brain bleeding or swelling. None of this counts toward the verdict.
Why do the amyloid drugs cause brain bleeding?
Gayatri Devi explains it on Attia's show. Some people carry amyloid in the walls of brain blood vessels, which can cause small bleeds on its own. The antibodies raise that risk, as swelling (ARIA-E) or bleeding (ARIA-H). People with two copies of APOE4 carry more of it, so the drugs are generally not used for them.
Does having amyloid mean you will get Alzheimer's?
Not always. In studies Precis has read only from their abstracts, plaque often showed up in people who stayed free of dementia. One estimated that most people with early, silent changes will never get dementia. Others found amyloid still raised the risk of decline. None of these studies counts yet.
If not amyloid, what causes Alzheimer's?
The record does not agree. Candidates include an immune response, inflammation, microglia turning destructive, and blood flow. No one has ranked these against each other.
Should I get an amyloid test?
Devi, on Attia's show, is careful about testing people with no symptoms unless they have a family history, because many people carry amyloid. She cites one expert group that wants amyloid, tau and symptoms before a diagnosis. That is a decision for a neurologist.

More Questions About Alzheimer's & Amyloid

Precis membership

Ask about anything in the corpus

The answer above is the whole answer: the verdict, every counted mention, where the sources disagree, and the receipt behind each one.

A free account adds

  • The full report on any topic in the corpus, with every receipt

Pro adds

  • Chat answers drawn from 3,800+ hours of recorded interviews with 380+ researchers and doctors, plus 87,700+ research studies, with a timestamp on every claim
Go Pro — $9/mo or $79/yr

How Precis checks a claim · Report an error